Status:
UNKNOWN
Peripheral Blood Monocytes as Predictive Marker for Colorectal Cancer Diagnosis: A Comparative Study of a Stool Based Versus Blood Based Screening Test
Lead Sponsor:
DNAlytics
Conditions:
Colorectal Cancer
Eligibility:
All Genders
56-74 years
Brief Summary
In this prospective study, the main goal is to evaluate the strength of Monomark -a monocyte-based transcriptomic test combined to a mathematical model- in patients with a positive FIT test. Therefore...
Detailed Description
Colorectal cancer (CRC) is the second leading cause of cancer death (approximately 9% of cancer deaths). In Belgium, a country with a population of 11,2 million people, every year 8600 patients get di...
Eligibility Criteria
Inclusion
- Having participated to the Flemish (Northern Belgium) Colorectal Screening Campaign and, as a result, having a positive stool test (FIT) outcome.
Exclusion
- None other than non-fulfillment of the inclusion criterion
Key Trial Info
Start Date :
December 11 2012
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 2 2018
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT03462992
Start Date
December 11 2012
End Date
May 2 2018
Last Update
March 13 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospitals Leuven
Leuven, Belgium, 3000